London MedTech Vicebio to be acquired by Sanofi in 拢1.2bn deal
A London-based MedTech developing vaccines against life threatening respiratory viral infections has been acquired by French firm Sanofi in a 拢1.2bn deal. Vicebio Ltd, which also has head offices in Australia and Belgium, has entered an exclusive, definitive agreement, which will include an upfront payment of 拢850m as well as development and regulatory milestones payments … Continue reading London MedTech Vicebio to be acquired by Sanofi in 拢1.2bn deal
